Late-phase trial activity in ovarian cancer has recovered from a recent decline

Phase III ovarian cancer trials by start year, 2017 to 2026 YTD

Data accessed 24 April 2026
Source: GlobalData Pharmaceutical Intelligence Center, Clinical Trials databaseGet the dataCreated with Datawrapper